Most people assume the body simply wears out — accumulating molecular errors until systems fail. A compelling theoretical review challenges that intuition, arguing that aging may be less about breakdown and more about biological programs running past their useful expiration date, with profound implications for how scientists target longevity interventions.

The hyperfunction theory, significantly developed by Mikhail Blagosklonny, posits that aging emerges from developmental and growth-signaling programs that persist and intensify beyond reproductive maturity. Rather than passive deterioration, this framework describes aging as a form of antagonistic pleiotropy: the same cellular machinery that drives early growth and survival becomes pathologically overactive in later life. Empirical pillars supporting this view include the discovery that single-gene manipulations — particularly in nutrient-sensing pathways — can meaningfully extend lifespan in animal models, and the well-documented finding that rapamycin, an mTOR inhibitor, extends lifespan across multiple species. The review traces this conceptual lineage from early caloric restriction experiments, which demonstrated that reducing nutrient signaling slows aging, to the modern molecular framework centered on mTOR hyperactivation.

This theoretical synthesis carries substantial weight in geroscience circles because it reorients the target of intervention: rather than trying to repair accumulated damage after the fact, the hyperfunction model suggests that dampening specific overactive signaling pathways could preempt aging pathology from the outset. That distinction matters clinically — it implies that senolytics and antioxidants alone may be insufficient if hyperactive mTOR and related growth signals remain unaddressed. The primary limitation here is that this is a theoretical review, not new empirical data, and the hyperfunction model remains most robustly validated in invertebrate and rodent models. Translation to human aging biology is still incomplete, and antagonistic pleiotropy effects are notoriously difficult to disentangle from pure damage accumulation in long-lived mammals. Nonetheless, as a conceptual framework, hyperfunction theory is increasingly influential and arguably the most mechanistically coherent programmatic account of aging available today.